ad
This Article
Right arrow Full Version
Services
Right arrow E-mail this link to a friend
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Section 1
Section 2
Section 3
Section 4
Section 5
Appendices
Right arrow Earn CME - What's This?
Related Collections
Right arrowRelated Articles

The following text is from an archived Red Book® edition and may not reflect current recommendations or information. To view the current edition, click here.

The first 20% of the full text of this section appears below.

Section 4. Antimicrobial Agents and Related Therapy

MEDWATCH—THE FDA SAFETY INFORMATION AND ADVERSE EVENT REPORTING PROGRAM

MedWatch, the Food and Drug Administration (FDA) Safety Information and Adverse Event Reporting Program, is an outreach program for the health care system, including physicians, nurses, pharmacists, and patients, to enhance the effectiveness of the FDA’s risk management activities for all regulated clinical medical products. These products include . . . [Go to Full Text]


Related Articles

Reporting of Adverse Events
Red Book 2006 2006: 41-50. [Extract] [Full Text]

Improving Blood Safety
Red Book 2006 2006: 121-123. [Extract] [Full Text]

Chlamydia trachomatis
Red Book 2006 2006: 252-257. [Extract] [Full Text]

Pertussis (Whooping Cough)
Red Book 2006 2006: 498-520. [Extract] [Full Text]